C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 31/7088 (2006.01) C07K 14/47 (2006.01)
Patent
CA 2517062
Novel MUC-1 DNA constructs are provided that have reduced homology to native MUC-1. Pharmaceutical compositions containing such MUC-1 constructs are provided.
L'invention concerne de nouveaux ADN MUC-1 recombinés, qui présentent une homologie réduite avec le MUC-1 naturel. L'invention concerne également des compositions pharmaceutiques contenant de tels MUC-1 recombinés.
Hamblin Paul Andrew
Rocha Del Cura Maria de Los Angeles
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Vaccines derived from epithelial cell mucin muc-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines derived from epithelial cell mucin muc-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines derived from epithelial cell mucin muc-1 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505066